NeurologyLive® Mind Moments®

143 Folgen

1. Special Episode: FDA Approval of Givinostat for Duchenne Muscular Dystrophy

   Vom: 29.3.2024
2. 111: Reviewing ACTRIMS 2024

   Vom: 22.3.2024
3. 110: Differential Diagnosis of Sleep Disorders and Hypersomnias

   Vom: 8.3.2024
4. 109: AB126, Exosomes, and Cerebroprotection for Stroke

   Vom: 23.2.2024
5. 108: Advancing the Genetic Pool of Parkinson Disease

   Vom: 9.2.2024
6. 107: Revealing Mechanisms of Sudden Unexplained Death in Toddlers

   Vom: 26.1.2024
7. 106: Potential Role of Stathmin-2 in Amyotrophic Lateral Sclerosis

   Vom: 12.1.2024
8. 105: Recapping Conversations in Neurology From 2023

   Vom: 29.12.2023
9. 104: Effects of Once-Nightly Sodium Oxybate on Narcolepsy Type 1 and 2

   Vom: 15.12.2023
10. 103: Advancing Epilepsy Care and Seizure Localization in Pediatrics

    Vom: 1.12.2023
11. 102: Potential of Gamma Sensory Stimulation in Alzheimer Disease

    Vom: 17.11.2023
12. Special Episode: FDA Greenlights Vamorolone for Duchenne Muscular Dystrophy

    Vom: 7.11.2023
13. 101: Ways to Enhance Neuromodulation in Parkinsonism

    Vom: 3.11.2023
14. Special Episode: FDA Approves Zilucoplan for Myasthenia Gravis

    Vom: 23.10.2023
15. 100: 2023 ECTRIMS-ACTRIMS Meeting Highlights

    Vom: 20.10.2023
16. 99: Understanding AMX0035's Potential in Progressive Supranuclear Palsy

    Vom: 5.10.2023
17. 98: Uncovering Phenotypical Features of Narcolepsy Type 1

    Vom: 22.9.2023
18. 97: Identifying Gaps in Access to Parkinson Disease Care

    Vom: 8.9.2023
19. 96: Complexities With Cognitive Screening in Primary Care Settings

    Vom: 25.8.2023
20. Special Episode: Addition of Valbenazine to Treat Huntington Disease Chorea

    Vom: 21.8.2023